Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD COPRTA · Entity 2375 | Director | May 15, 2026 | May 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROTHENA CORP PUBLIC LTD CO
Report date May 15, 2026 · Filed May 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.76 · Expires 2036-05-15 | Direct | 27,000 |
Reported balance
After 2026-05-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 27,000 · Balance 27,000 F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 16, 2026 01:28 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 27,000 | $0.00 Strike: $9.76 | $0.00 |
DisclosureSEC source: 0000905148-26-002466 · form4.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: Ordinary Shares · 27,000 shares Expires 2036-05-15 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:46 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 20,183 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0000905148-25-001827 · form4.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,183 Underlying: Ordinary Shares · 20,183 shares Expires 2035-05-14 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $22.39 | $0.00 |
DisclosureSEC source: 0000905148-24-001530 · form4.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2034-05-15 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 17, 2023 Filed May 20, 2023 01:31 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $76.00 | $0.00 |
DisclosureSEC source: 0001140361-23-025830 · form4.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 02:38 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-23-000573 · doc1.xml · derivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. F3 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 02:38 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 5,000 | $52.67 | $263,350.00 |
DisclosureSEC source: 0001567619-23-000573 · doc1.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $52.215 to $53.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 02:38 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-23-000573 · doc1.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · derivative · entry 7 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. F7 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 949 | $65.02 | $61,701.13 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 6 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The transaction was executed in multiple trades in prices ranging from $64.66 to $65.62, inclusive. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 647 | $63.83 | $41,295.87 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 5 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $63.465 to $64.145, inclusive. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 576 | $62.71 | $36,121.13 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 4 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,815 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $62.19 to $63.06, inclusive. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 913 | $61.13 | $55,808.59 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,391 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $60.87 to $61.65, inclusive. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 1,915 | $60.28 | $115,429.31 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,304 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $59.72 to $60.67, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 6 of this Form 4. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 02:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 02:30 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-22-019408 · doc1.xml · derivative · entry 5 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. F5 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 02:30 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 826 | $56.89 | $46,995.02 |
DisclosureSEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 4 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $56.37 to $57.23, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 02:30 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 2,688 | $55.71 | $149,739.88 |
DisclosureSEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $55.29 to $56.27, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 02:30 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 1,486 | $54.74 | $81,348.25 |
DisclosureSEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $54.29 to $55.195, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4. Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 02:30 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2022 Filed Oct 8, 2022 01:36 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-22-018377 · doc1.xml · derivative · entry 6 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. F6 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. Read SEC document |
| October 05, 2022 Filed Oct 8, 2022 01:36 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 354 | $59.95 | $21,221.80 |
DisclosureSEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 5 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $59.90 to $60.00, inclusive. Read SEC document |
| October 05, 2022 Filed Oct 8, 2022 01:36 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 352 | $58.94 | $20,747.51 |
DisclosureSEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 4 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $58.585 to $59.30, inclusive. Read SEC document |
| October 05, 2022 Filed Oct 8, 2022 01:36 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 3,404 | $57.97 | $197,333.62 |
DisclosureSEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $57.53 to $58.48, inclusive. Read SEC document |
| October 05, 2022 Filed Oct 8, 2022 01:36 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 890 | $56.54 | $50,318.82 |
DisclosureSEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,329 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $56.37 to $56.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 5 of this Form 4. Read SEC document |
| October 05, 2022 Filed Oct 8, 2022 01:36 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2022 Filed Oct 1, 2022 01:31 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001140361-22-035562 · form4.xml · derivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 25,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. F2 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. Read SEC document |
| September 28, 2022 Filed Oct 1, 2022 01:31 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 25,000 | $48.09 | $1,202,250.00 |
DisclosureSEC source: 0001140361-22-035562 · form4.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 28, 2022 Filed Oct 1, 2022 01:31 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionOrdinary Shares, par value $0.01 per share | 25,000 | $6.41 | $160,250.00 |
DisclosureSEC source: 0001140361-22-035562 · form4.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2022 Filed May 28, 2022 01:30 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $25.60 | $0.00 |
DisclosureSEC source: 0001140361-22-021106 · form4.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2032-05-18 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2023 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-22-008265 · doc1.xml · derivative · entry 4 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately 10 months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. F2 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately 10 months and be forfeited to the extent it is not exercised on or prior to January 29, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 2,369 | $39.66 | $93,954.07 |
DisclosureSEC source: 0001567619-22-008265 · doc1.xml · nonDerivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $39.51 to $40.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | SaleOrdinary Shares, par value $0.01 per share | 2,631 | $39.18 | $103,072.58 |
DisclosureSEC source: 0001567619-22-008265 · doc1.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,588 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $38.485 to $39.47, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-22-008265 · doc1.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:05 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $23.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010960 · doc1.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 6 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 5 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 4 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:39 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011034 · doc1.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:08 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012075 · doc1.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:16 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $16.43 | $0.00 |
DisclosureSEC source: 0000899243-18-013417 · doc4.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2019 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:05 UTC | PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $56.23 | $0.00 |
DisclosureSEC source: 0000899243-17-013893 · doc4.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2018 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.